Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer’s Disease

Clinical diagnosis of Alzheimer’s disease (AD) is based on symptoms; however, the challenge is to diagnose AD at the preclinical stage with the application of biomarkers and initiate early treatment (still not widely available). Currently, cerebrospinal fluid (CSF) amyloid-β 42 (Aβ(42)) and tau are...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Alzheimers Dis Rep
Prif Awduron: Hameed, Shahul, Fuh, Jong-Ling, Senanarong, Vorapun, Ebenezer, Esther Gunaseli M., Looi, Irene, Dominguez, Jacqueline C., Park, Kyung Won, Karanam, Ananda Krishna, Simon, Oliver
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: IOS Press 2020
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7081089/
https://ncbi.nlm.nih.gov/pubmed/32206755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/ADR-190143
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg